Anuncio
Anuncio

RVPH

RVPH logo

Reviva Pharmaceuticals Holdings, Inc. Common Stock

0.37
USD
Patrocinado
+0.01
+1.37%
09 ene, 12:50 UTC -5
Apertura

Informes de beneficios de RVPH

Ratio de Sorpresa Positivo

RVPH superó 13 de las últimas 18 estimaciones.

72%

Próximo informe

Fecha del próximo informe
30 mar 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.08
Cambio implícito desde Q3 25 (Revenue/ EPS)
--
/
+33.33%
Cambio implícito desde Q4 24 (Revenue/ EPS)
--
/
-46.67%

Reviva Pharmaceuticals Holdings, Inc. Common Stock earnings per share and revenue

On 13 nov 2025, RVPH reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.09 USD, resulting in a 39.46% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -7.19% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analistas forecast an EPS of -0.08 USD, with revenue projected to reach -- USD, implying an aumentar of 33.33% EPS, and aumentar of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 dic 2025 para Q4 25
Estimar
-$0.49
Actual
-
Sorpresa
-
Preguntas frecuentes
For Q3 2025, Reviva Pharmaceuticals Holdings, Inc. Common Stock reported EPS of -$0.06, beating estimates by 39.46%, and revenue of $0.00, 0% as expectations.
The stock price moved down -7.19%, changed from $0.54 before the earnings release to $0.50 the day after.
The next earning report is scheduled for 30 mar 2026.
Based on 10 analistas, Reviva Pharmaceuticals Holdings, Inc. Common Stock is expected to report EPS of -$0.08 and revenue of -- for Q4 2025.
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio